|
Innovative, Effective Surgical Treatment
Dr. James Mirabile states, “Although so many women experience sudden urine loss, most women are not aware that it is a treatable condition. Women may suffer in silence and put off activities that they enjoy. GYNECARE TVT is a proven treatment that can help women to live free from leakage.” GYNECARE TVT is used in a 30-minute, minimally-invasive treatment that can be performed under local anesthesia in an outpatient setting. The treatment can restore the body’s ability to control urine loss. GYNECARE TVT is not for women who are or intend to become pregnant. Female stress urinary incontinence (SUI) is caused in part by an improperly functioning urethra. Unlike other types of incontinence, SUI is not a problem of the bladder. Normally, the urethra maintains a tight seal to prevent involuntary loss of urine. In a woman with SUI, muscle and pelvic tissue weakened by childbirth or other causes are unable to adequately support the urethra in its correct position. As a result, when pressure is exerted on the bladder from the diaphragm during sudden movements, the urethra cannot maintain its seal and urine escapes. GYNECARE TVT combines the use of a PROLENE polypropylene mesh tape with a traditional surgical procedure known as a sling to correct SUI. The mesh is woven through pelvic tissue and positioned underneath the urethra, creating a supportive sling. When pressure is exerted, the tape provides the supported needed to allow the urethra to maintain its seal. Dr. James Mirabile says, “One of the benefits of GYNECARE TVT is that because it can be performed under local anesthesia the patient is awake and we can do an intra-operative test to assess the results of the surgery. By asking the patient to cough we can check the tension of the tape and make any adjustments. This can help to improve success rates.” Patients treated with GYNECARE TVT may be able to go home as early as a few hours after the procedure. Patients can expect a two to three week recovery period. During this time, there should be little interference with daily activities. The patient may be advised to avoid heavy lifting and intercourse for four to six weeks. All medical procedures present risks. Although rare, complications associated with GYNECARE TVT include injury to blood vessels of the pelvic sidewall and abdominal wall, difficulty urinating and bladder and bowel injury. For more information on this treatment, consumers can visit www.ControlSuddenUrineLoss.com or call 1-888-GYNECARE or contact For Women Only at 1-888-97OBGYN. ETHICON Women's Health and Urology is dedicated to providing innovative, minimally invasive treatments for common urologic and women’s health conditions. The division offers solutions for enlarged prostate (benign prostatic hyperplasia), female stress urinary incontinence, pelvic floor repair, post-surgical adhesions, heavy periods (menorrhagia) and benign uterine conditions such as fibroids and polyps. ETHICON Women's Health & Urology is a division of ETHICON, Inc., a Johnson & Johnson company. For more information, please visit www.gynecare.com. |
Millions of women have sudden urine loss or stress urinary incontinence. The condition causes them to leak urine when they laugh, sneeze, cough, or during exercise. For Women Only offers a simple, proven outpatient treatment option for women experiencing this condition. The treatment, called GYNECARE TVT Tension-free Support for Incontinence, has been performed on over one million women worldwide. A recent study shows that even seven years after treatment, 81 percent of women treated remained dry, while an additional 16 percent experienced significant improvement.